Name, image and likeness (NIL) deals have flooded college sports with hundreds of millions of dollars — but universities and team general managers have been operating with little formal oversight, ...

For robotaxies to be economical, remote operators must be able to handle far more vehicles than they currently do. Mobileye has a new architecture that offloads some non-safety computations to the ...

The US Federal Trade Commission is taking a closer look at moves by major tech companies to hire away the employees of a startup instead of buying the venture outright, the agency’s Chairman Andrew ...

Lawmakers on Capitol Hill expressed concern Wednesday about the antitrust review process under President Trump’s administration and warned about the impact on consumers from a planned sale of Warner ...

Charter Communications Inc (NASDAQ:CHTR) is one of the best beaten down stocks to invest in according to analysts. On December 22, UBS analyst John Hodulik reiterated a Hold on Charter Communications ...

Allan Sun is a software and systems engineer at Apple, where he works on real-time system software and infrastructure for Apple’s in-house 5G modem silicon platforms (C1X), one of the company’s most ...

President Donald Trump said Sunday that the proposed $72 billion merger between Netflix and Warner Bros. Discovery "could be a problem" because of the amount of market share the resulting company ...

Word of revised bids by the three companies looking to acquire all or part of Warner Bros. Discovery surfaced Monday, the day designated by the media giant as the deadline for the next round of offers ...

Agentic AI, the buzzy term for autonomous systems that can plan, act and adapt with minimal human input, is being marketed as the holy grail of digital transformation. And don't get me wrong: It's ...

(The Center Square) – Attorneys general in three states are asking federal regulators to approve the proposed merger between Union Pacific and Norfolk Southern. Their letter comes one week after nine ...

ZURICH, Oct. 29, 2025 /PRNewswire/ -- NLS Pharmaceutics Ltd. (NLSP) (NASDAQ: NLSP) (NASDAQ: NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company focused on the discovery ...